PHR,TDOC,JAZZ Stock Price and Quote

NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Dollar change -1.95
Percentage change -6.80	%

Peers: VEEV UNH TDOC EVH GEHC ADP MASI BLKB HIMS HSTM

| Held by: VTI IWM VXF VB IWO VBK SCHA VTWO FESM VHT

Index	RUT	P/E	-	EPS (ttm)	-0.74	Insider Own	7.97%	Shs Outstand	59.46M	Perf Week	-7.83%
Market Cap	1.59B	Forward P/E	109.59	EPS next Y	0.24	Insider Trans	-6.78%	Shs Float	54.76M	Perf Month	-4.64%
Enterprise Value	1.51B	PEG	-	EPS next Q	-0.06	Inst Own	92.82%	Short Float	6.52%	Perf Quarter	6.03%
Income	-42.72M	P/S	3.66	EPS this Y	85.65%	Inst Trans	4.28%	Short Ratio	6.52	Perf Half Y	-0.96%
Sales	434.53M	P/B	5.63	EPS next Y	266.52%	ROA	-11.06%	Short Interest	3.57M	Perf YTD	6.20%
Book/sh	4.75	P/C	17.50	EPS next 5Y	-	ROE	-15.97%	52W High	30.53 -12.48%	Perf Year	32.02%
Cash/sh	1.53	P/FCF	43.47	EPS past 3/5Y	24.57% 16.05%	ROIC	-14.79%	52W Low	17.07 56.53%	Perf 3Y	4.46%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	25.33% 27.46%	Gross Margin	61.15%	Volatility	3.77% 3.69%	Perf 5Y	-7.32%
Dividend TTM	-	EV/Sales	3.49	EPS Y/Y TTM	66.01%	Oper. Margin	-9.66%	ATR (14)	0.99	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.94	Sales Y/Y TTM	16.29%	Profit Margin	-9.83%	RSI (14)	45.24	Recom	1.13
Dividend Gr. 3/5Y	- -	Current Ratio	1.94	EPS Q/Q	80.92%	SMA20	-3.01%	Beta	0.71	Target Price	32.14
Payout	-	Debt/Eq	0.06	Sales Q/Q	14.54%	SMA50	1.64%	Rel Volume	0.92	Prev Close	28.67
Employees	2082	LT Debt/Eq	0.02	Earnings	May 28 BMO	SMA200	8.26%	Avg Volume	547.43K	Price	26.72
IPO	Jul 18, 2019	Option/Short	Yes / Yes	EPS/Sales Surpr.	42.53% 0.88%	Trades		Volume	504,545	Change	-6.80%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-08-25	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$24 → $32
Feb-26-24	Initiated	Truist	Buy	$35
Jan-17-24	Upgrade	DA Davidson	Neutral → Buy	$30 → $32
Jan-03-24	Initiated	Barclays	Overweight	$29
Apr-12-23	Initiated	Stephens	Overweight	$37
Jan-04-23	Reiterated	Needham	Buy	$35 → $40
Dec-13-22	Upgrade	Citigroup	Neutral → Buy	$40
Dec-09-22	Upgrade	SVB Leerink	Mkt Perform → Outperform	$31 → $34
Oct-13-22	Initiated	DA Davidson	Neutral	$25
Sep-16-22	Initiated	KeyBanc Capital Markets	Overweight	$40
Apr-14-22	Initiated	Guggenheim	Buy	$45
Jan-06-22	Downgrade	SVB Leerink	Outperform → Mkt Perform	$57 → $41
Dec-02-21	Initiated	Jefferies	Buy	$70
Sep-02-21	Reiterated	Needham	Buy	$70 → $81
Aug-27-21	Initiated	Canaccord Genuity	Buy	$81
Jul-13-21	Initiated	JMP Securities	Mkt Outperform	$80
Jun-08-21	Initiated	Berenberg	Buy	$70
Apr-29-21	Resumed	JP Morgan	Overweight	$64
Apr-01-21	Initiated	Robert W. Baird	Outperform	$60
Nov-11-20	Initiated	Stephens	Overweight	$50

Show Previous Ratings

Jul-09-25 04:05PM	Phreesia Named in Black Book Researchs List of 2025s Top-Rated Vendors for Patient Access and Front-End Management Solutions in Revenue Cycle Management (Business Wire)
Jul-08-25 08:49AM	Indig: AI has been wildly effective for us, our providers, and patients (CNBC TV)
Jun-12-25 04:05PM	Beckers Names Phreesias Kristin Roberts as one of 2025s 100 Women in Health IT to Know (Business Wire) -5.57%
Jun-02-25 12:00PM	Phreesia (PHR) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
May-29-25 11:33PM	Q1 Earnings Outperformers: Phreesia (NYSE:PHR) And The Rest Of The Healthcare Technology for Providers Stocks (StockStory)
08:55AM	Loading…
08:55AM	Morning Movers: Abercrombie & Fitch skyrockets following first quarter results (TipRanks)
03:03AM	Phreesia Inc (PHR) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic AI ... (GuruFocus.com)
May-28-25 12:25PM	PHR Q1 Earnings Call: Revenue Misses, Profitability Surges Amid Product Expansion (StockStory) -6.61%
12:25PM	PHR Q1 Earnings Call: Profitability Surges Amid Product Expansion (StockStory)
09:30AM	Here's What Key Metrics Tell Us About Phreesia (PHR) Q1 Earnings (Zacks)
08:15AM	Phreesia (PHR) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:17AM	Phreesia (NYSE:PHR) Surprises With Q1 Sales (StockStory)
07:09AM	Phreesia: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
07:03AM	Phreesia Announces First Quarter Fiscal 2026 Results (Business Wire)
May-27-25 03:03AM	Phreesia (PHR) Reports Q1: Everything You Need To Know Ahead Of Earnings (StockStory)
09:15AM	Loading…
May-26-25 09:15AM	Gear Up for Phreesia (PHR) Q1 Earnings: Wall Street Estimates for Key Metrics (Zacks)
May-21-25 12:01AM	3 Reasons to Sell PHR and 1 Stock to Buy Instead (StockStory)
May-08-25 07:20AM	Privia Health (PRVA) Misses Q1 Earnings Estimates (Zacks)
May-07-25 07:05PM	TruBridge (TBRG) Lags Q1 Earnings Estimates (Zacks)
May-06-25 04:05PM	Phreesia Updates May 28, 2025, Earnings Release Information for Fiscal First Quarter 2026 Results (Business Wire)
Apr-29-25 09:01AM	1 Cash-Heavy Stock with Impressive Fundamentals and 2 to Ignore (StockStory)
06:40AM	Phreesia Sets Release Date for Fiscal First Quarter 2026 Results (Business Wire)
05:06AM	Winners And Losers Of Q4: Evolent Health (NYSE:EVH) Vs The Rest Of The Healthcare Technology for Providers Stocks (StockStory)
Apr-28-25 05:04AM	Unpacking Q4 Earnings: Omnicell (NASDAQ:OMCL) In The Context Of Other Healthcare Technology for Providers Stocks (StockStory)
Apr-11-25 01:15PM	Buy Certara After The FDA Announcement (Seeking Alpha)
Apr-04-25 09:55AM	Wall Street Analysts Think Phreesia (PHR) Could Surge 28.02%: Read This Before Placing a Bet (Zacks)
Mar-19-25 09:03AM	1 Small-Cap Stock with Solid Fundamentals and 2 to Ignore (StockStory) +6.34%
Mar-14-25 05:02AM	Q4 Earnings Review: Healthcare Technology for Providers Stocks Led by Phreesia (NYSE:PHR) (StockStory)
Mar-13-25 04:06PM	Phreesia Named to G2s List of 2025 Best Healthcare Software Products (Business Wire) +6.93%
07:30AM	Q4 2025 Phreesia Inc Earnings Call (Thomson Reuters StreetEvents)
03:09AM	Loading…
03:09AM	Phreesia Inc (PHR) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Positive Cash Flow (GuruFocus.com)
Mar-12-25 05:30PM	Phreesia (PHR) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
05:15PM	Phreesia (PHR) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:40PM	Phreesia (NYSE:PHR) Posts Better-Than-Expected Sales In Q4 But Stock Drops (StockStory)
04:17PM	Phreesia: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
04:03PM	Phreesia Announces Fourth Quarter Fiscal 2025 Results (Business Wire)
Mar-11-25 08:02AM	Phreesia (PHR) To Report Earnings Tomorrow: Here Is What To Expect (StockStory) +5.74%
Feb-14-25 07:02AM	Phreesia (PHR) Moves 5.6% Higher: Will This Strength Last? (Zacks)
Feb-11-25 01:45PM	Why Insiders Are Selling Phreesia, Inc. (PHR) Recently (Insider Monkey)
06:48AM	Phreesias Sally Thayer Selected as a Top Woman Leader in Software (Business Wire)
Feb-07-25 04:15PM	Phreesia Sets Release Date for Fiscal Fourth Quarter and Fiscal Year 2025 Results (Business Wire)
Jan-29-25 09:15AM	Phreesia, Inc. (PHR) Soars to 52-Week High, Time to Cash Out? (Zacks)
Jan-14-25 12:00PM	Phreesia (PHR) Upgraded to Buy: Here's Why (Zacks)
Jan-08-25 09:55AM	Should You Buy Phreesia (PHR) After Golden Cross? (Zacks) +5.37%
Dec-20-24 09:55AM	Wall Street Analysts See a 25% Upside in Phreesia (PHR): Can the Stock Really Move This High? (Zacks) +5.54%
Dec-12-24 07:17AM	Phreesia price target lowered to $30 from $34 at Baird (TipRanks)
Dec-10-24 08:13AM	Q3 2025 Phreesia Inc Earnings Call (Thomson Reuters StreetEvents) +11.60%
02:01AM	Phreesia Inc (PHR) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Positive Cash Flow (GuruFocus.com)
Dec-09-24 06:00PM	Phreesia (PHR) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks)
05:20PM	Phreesia (PHR) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:21PM	Phreesia: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Phreesia Announces Third Quarter Fiscal 2025 Results (Business Wire)
Dec-06-24 09:15AM	Curious about Phreesia (PHR) Q3 Performance? Explore Wall Street Estimates for Key Metrics (Zacks)
Nov-22-24 06:48AM	Phreesia Named to The Software Reports Top 100 Software Companies for the Third Consecutive Year (Business Wire)
Nov-07-24 04:26AM	Phreesia (PHR) Moves 13.9% Higher: Will This Strength Last? (Zacks)
Nov-01-24 06:48AM	Phreesia Sets Release Date for Fiscal Third Quarter 2025 Results (Business Wire)
Oct-28-24 06:48AM	Phreesia Achieves Oracle Validated Integration With Oracle Health EHR Expertise for Delivering Proven, Repeatable Integration (Business Wire)
Oct-11-24 12:14PM	Is Phreesia, Inc. (NYSE:PHR) The Top Stock With Improving Technical Ratings According To Piper Sandler? (Insider Monkey)
Oct-10-24 09:35AM	Down -10.25% in 4 Weeks, Here's Why Phreesia (PHR) Looks Ripe for a Turnaround (Zacks)
Oct-08-24 06:48AM	Phreesia Joins the Network Advertising Initiative as a Member, Demonstrating Ongoing Commitment to Industry-Leading Privacy Practices (Business Wire)
Oct-03-24 06:48AM	Phreesia and Ad Council Partnership Yields High Patient Engagement in 3 Mental Health Awareness Campaigns (Business Wire)
Oct-01-24 06:48AM	Phreesia Secures New Contract With CMS as Report Shows Gains in Patient Activation in First Year of Kidney Care Choices (KCC) Model (Business Wire)
Sep-19-24 06:48AM	New Research Shows Point-of-Care Patient Outreach Supports Vaccine Confidence and Adoption (Business Wire)
Sep-17-24 04:28PM	CDC Awards Grant to NAFC, Phreesia and Health.Equity.Outcomes. to Tackle Public Health Challenge of Urinary Incontinence (Business Wire)
Sep-05-24 12:39PM	Q2 2025 Phreesia Inc Earnings Call (Thomson Reuters StreetEvents) +6.29%
Sep-04-24 06:00PM	Phreesia (PHR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:15PM	Phreesia (PHR) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:15PM	Phreesia: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
04:03PM	Phreesia Announces Second Quarter Fiscal 2025 Results (Business Wire)
Sep-03-24 09:03AM	Earnings To Watch: Phreesia Inc (PHR) Reports Q2 2025 Result (GuruFocus.com) -7.43%
Aug-29-24 09:15AM	Phreesia (PHR) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures (Zacks)
06:48AM	Phreesia and American Academy of Pediatrics Join in Campaign to Increase Childhood MMR Vaccination (Business Wire)
Aug-08-24 06:48AM	Bob Glazer Joins Phreesia as Strategic Advisor (Business Wire)
Aug-05-24 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating Helen of Troy, Owens & Minor, Salesforce, and Phreesia and Encourages Investors to Contact the Firm (GlobeNewswire)
Aug-01-24 06:48AM	Phreesia Sets Release Date for Fiscal Second Quarter 2025 Results (Business Wire)
Jul-30-24 06:48AM	Phreesia Now Available on Oracle Healthcare Marketplace (Business Wire)
Jul-19-24 09:55AM	Wall Street Analysts Think Phreesia (PHR) Could Surge 27.77%: Read This Before Placing a Bet (Zacks)
Jul-12-24 12:00PM	Phreesia (PHR) Upgraded to Strong Buy: Here's What You Should Know (Zacks)
Jun-10-24 10:26AM	New Research Illustrates How to Drive Earlier Diagnosis and Treatment of Kidney Disease (Business Wire)
Jun-04-24 09:35AM	Here's Why Phreesia (PHR) is Poised for a Turnaround After Losing -18.25% in 4 Weeks (Zacks)
May-31-24 11:59AM	Q1 2025 Phreesia Inc Earnings Call (Thomson Reuters StreetEvents) -11.22%
May-30-24 08:54PM	PHR Stock Earnings: Phreesia Beats EPS, Beats Revenue for Q1 2025 (InvestorPlace)
05:30PM	Compared to Estimates, Phreesia (PHR) Q1 Earnings: A Look at Key Metrics (Zacks)
05:15PM	Phreesia (PHR) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:08PM	Phreesia: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
04:03PM	Phreesia Announces First Quarter Fiscal 2025 Results (Business Wire)
May-28-24 06:48AM	Phreesia Joins the MEDITECH Alliance Program as an Innovator Partner (Business Wire)
May-24-24 09:15AM	Unlocking Q1 Potential of Phreesia (PHR): Exploring Wall Street Estimates for Key Metrics (Zacks)
May-23-24 04:30PM	Phreesias Amy Patel Named One of PM360s 2024 ELITE 100 (Business Wire)
May-21-24 04:30PM	Phreesia Named as One of Modern Healthcares Best Places to Work in Healthcare for the Eighth Time (Business Wire)
May-01-24 06:46AM	Phreesias Alicia Cowley and Natasha Vega Named to MM+Ms Women to Watch for 2024 (Business Wire)
Apr-29-24 06:48AM	Phreesia Sets Release Date for Fiscal First Quarter 2025 Results (Business Wire)
Mar-25-24 07:01PM	Insider Sell: COO Evan Roberts Sells 25,962 Shares of Phreesia Inc (PHR) (GuruFocus.com)
Mar-19-24 06:48AM	Phreesia Announces Jack Callahan as New Chief Technology Officer (Business Wire)
Mar-17-24 10:22AM	Phreesia, Inc. (NYSE:PHR) Q4 2024 Earnings Call Transcript (Insider Monkey)
Mar-15-24 06:56AM	Q4 2024 Phreesia Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-14-24 08:55PM	PHR Stock Earnings: Phreesia Misses EPS, Beats Revenue for Q4 2024 (InvestorPlace)
06:00PM	Phreesia (PHR) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:25PM	Phreesia (PHR) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:22PM	Phreesia: Fiscal Q4 Earnings Snapshot (Associated Press Finance)

Phreesia, Inc. engages in the provision of patient check-in solutions for medical practices. The firm offers appointments, clinical support, integration, registration, patient activation, analytics and reports, revenue cycle, patient surveys, and privacy and security products. Its solutions include health systems, multi-specialty, and federally qualified health centers (FQHCs). The company was founded by Chaim Indig and Evan Roberts in January 2005 and is headquartered in Wilmington, DE.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hui Yvonne	Principal Accounting Officer	Jul 07 '25	Sale	28.85	571	16,473	31,010	Jul 08 05:21 PM
Hui Yvonne	Officer	Jul 07 '25	Proposed Sale	28.85	571	16,473		Jul 07 04:31 PM
Smith Mark Douglas	Director	Jul 02 '25	Option Exercise	4.71	7,000	32,970	44,353	Jul 03 07:34 PM
Smith Mark Douglas	Director	Jul 02 '25	Sale	29.00	7,000	203,000	37,353	Jul 03 07:34 PM
Smith Mark Douglas	Director	Jul 02 '25	Proposed Sale	29.00	7,000	203,000		Jul 02 04:55 PM
Linetsky David	SVP, Network Solutions	Jun 27 '25	Sale	28.50	23,729	676,196	193,510	Jul 01 09:41 PM
Egbuonu-Davis Lisa	Director	Jun 26 '25	Sale	27.67	2,802	77,531	22,037	Jun 27 05:24 PM
Linetsky David	Officer	Jun 27 '25	Proposed Sale	28.50	23,729	676,195		Jun 27 05:11 PM
Egbuonu-Davis Lisa	Director	Jun 26 '25	Proposed Sale	27.67	2,802	77,531		Jun 26 09:39 AM
Linetsky David	SVP, Network Solutions	Jun 18 '25	Sale	25.61	67	1,716	9,795	Jun 20 04:49 PM
Linetsky David	SVP, Network Solutions	Jun 17 '25	Sale	25.17	42	1,057	9,862	Jun 20 04:49 PM
Linetsky David	Member of immediate family of	Jun 18 '25	Proposed Sale	25.61	67	1,716		Jun 18 03:40 PM
Linetsky David	Member of immediate family of	Jun 17 '25	Proposed Sale	25.17	42	1,057		Jun 17 03:30 PM
Weintraub Michael	Director	Jun 09 '25	Option Exercise	4.71	7,431	35,000	150,470	Jun 11 05:21 PM
Weintraub Michael	Director	Jun 10 '25	Option Exercise	4.71	2,569	12,100	145,608	Jun 11 05:21 PM
Weintraub Michael	Director	Jun 09 '25	Sale	27.51	7,431	204,444	143,039	Jun 11 05:21 PM
Weintraub Michael	Director	Jun 10 '25	Sale	27.86	2,569	71,568	143,039	Jun 11 05:21 PM
Hui Yvonne	Principal Accounting Officer	Jun 10 '25	Sale	28.00	582	16,296	31,010	Jun 11 05:18 PM
Weintraub Michael	Director	Jun 10 '25	Proposed Sale	27.86	2,569	71,568		Jun 10 04:22 PM
Hui Yvonne	Officer	Jun 10 '25	Proposed Sale	28.00	582	16,296		Jun 10 03:09 PM
Weintraub Michael	Director	Jun 09 '25	Proposed Sale	27.51	7,431	204,444		Jun 09 04:09 PM
Linetsky David	SVP, Life Sciences	Apr 21 '25	Sale	23.04	260	5,991	8,752	Apr 23 04:24 PM
Hui Yvonne	Principal Accounting Officer	Apr 22 '25	Sale	23.70	1,330	31,521	22,592	Apr 23 04:15 PM
Hui Yvonne	Principal Accounting Officer	Apr 21 '25	Sale	23.04	993	22,881	23,922	Apr 23 04:15 PM
Hui Yvonne	Officer	Apr 22 '25	Proposed Sale	23.70	1,330	31,521		Apr 22 09:55 AM
Hui Yvonne	Officer	Apr 21 '25	Proposed Sale	23.04	993	22,881		Apr 21 04:11 PM
Linetsky David	Member of immediate family of	Apr 21 '25	Proposed Sale	23.04	260	5,991		Apr 21 04:10 PM
Linetsky David	SVP, Life Sciences	Apr 16 '25	Sale	23.73	4,499	106,742	217,239	Apr 17 05:05 PM
VanDuyn Amy Beth	SVP, Human Resources	Apr 16 '25	Sale	23.81	624	14,856	129,820	Apr 17 05:02 PM
Roberts Evan	Chief Operating Officer	Apr 16 '25	Sale	23.81	1,845	43,924	774,807	Apr 17 05:01 PM
Indig Chaim	Chief Executive Officer	Apr 16 '25	Sale	23.81	3,091	73,588	1,254,574	Apr 17 05:00 PM
Hui Yvonne	Principal Accounting Officer	Apr 16 '25	Sale	23.66	418	9,890	24,915	Apr 17 05:00 PM
Hui Yvonne	Principal Accounting Officer	Apr 15 '25	Sale	24.04	314	7,550	25,333	Apr 17 05:00 PM
Hoffman Allison C	General Counsel & Secretary	Apr 16 '25	Sale	23.81	1,213	28,878	137,921	Apr 17 04:59 PM
Gandhi Balaji	Chief Financial Officer	Apr 16 '25	Sale	23.81	864	20,569	107,547	Apr 17 04:58 PM
VanDuyn Amy Beth	Officer	Apr 16 '25	Proposed Sale	23.81	624	14,856		Apr 16 03:25 PM
Indig Chaim	Officer	Apr 16 '25	Proposed Sale	23.81	3,091	73,588		Apr 16 03:18 PM
Roberts Evan	Officer	Apr 16 '25	Proposed Sale	23.81	1,845	43,924		Apr 16 03:14 PM
Hoffman Allison C	Officer	Apr 16 '25	Proposed Sale	23.81	1,213	28,878		Apr 16 03:13 PM
Linetsky David	Officer	Apr 16 '25	Proposed Sale	23.81	2,011	47,876		Apr 16 03:10 PM
Gandhi Balaji	Officer	Apr 16 '25	Proposed Sale	23.81	864	20,569		Apr 16 03:07 PM
Hui Yvonne	Officer	Apr 16 '25	Proposed Sale	23.66	418	9,890		Apr 16 12:07 PM
Linetsky David	Officer	Apr 16 '25	Proposed Sale	23.66	2,488	58,866		Apr 16 10:00 AM
Hui Yvonne	Officer	Apr 15 '25	Proposed Sale	24.04	314	7,550		Apr 15 03:21 PM
Linetsky David	SVP, Life Sciences	Apr 08 '25	Sale	23.85	3,944	94,076	221,738	Apr 10 08:59 PM
Linetsky David	SVP, Life Sciences	Apr 08 '25	Sale	23.85	248	5,915	9,012	Apr 10 08:59 PM
Indig Chaim	Chief Executive Officer	Apr 08 '25	Sale	23.85	12,167	290,218	1,257,665	Apr 10 08:58 PM
VanDuyn Amy Beth	SVP, Human Resources	Apr 08 '25	Sale	23.85	1,695	40,430	130,444	Apr 10 08:57 PM
Roberts Evan	Chief Operating Officer	Apr 08 '25	Sale	23.85	7,233	172,527	776,652	Apr 10 08:56 PM
Hui Yvonne	Principal Accounting Officer	Apr 09 '25	Sale	23.23	2,802	65,090	25,647	Apr 10 08:55 PM
Hui Yvonne	Principal Accounting Officer	Apr 08 '25	Sale	23.85	1,878	44,795	28,449	Apr 10 08:55 PM
Hoffman Allison C	General Counsel & Secretary	Apr 08 '25	Sale	23.85	6,024	143,689	143,830	Apr 10 08:55 PM
Hoffman Allison C	General Counsel & Secretary	Apr 09 '25	Sale	23.23	4,696	109,088	139,134	Apr 10 08:55 PM
Gandhi Balaji	Chief Financial Officer	Apr 08 '25	Sale	23.85	8,045	191,896	108,411	Apr 10 08:53 PM
Hoffman Allison C	Officer	Apr 09 '25	Proposed Sale	23.23	4,696	109,088		Apr 09 10:26 AM
Hui Yvonne	Officer	Apr 09 '25	Proposed Sale	23.23	2,802	65,090		Apr 09 10:24 AM
Roberts Evan	Officer	Apr 08 '25	Proposed Sale	23.85	7,233	172,528		Apr 08 04:44 PM
Indig Chaim	Officer	Apr 08 '25	Proposed Sale	23.85	12,167	290,218		Apr 08 04:32 PM
Hui Yvonne	Officer	Apr 08 '25	Proposed Sale	23.85	1,878	44,796		Apr 08 04:29 PM
Hoffman Allison C	Officer	Apr 08 '25	Proposed Sale	23.85	6,024	143,690		Apr 08 04:25 PM
Gandhi Balaji	Officer	Apr 08 '25	Proposed Sale	23.85	8,045	191,897		Apr 08 04:21 PM
Linetsky David	Member of immediate family of	Apr 08 '25	Proposed Sale	23.85	248	5,916		Apr 08 04:20 PM
Linetsky David	Officer	Apr 08 '25	Proposed Sale	23.85	3,944	94,076		Apr 08 04:18 PM
VanDuyn Amy Beth	Officer	Apr 08 '25	Proposed Sale	23.85	1,695	40,431		Apr 08 04:17 PM
Gandhi Balaji	Chief Financial Officer	Mar 26 '25	Sale	27.46	1,827	50,177	103,591	Mar 28 04:13 PM
Gandhi Balaji	Officer	Mar 26 '25	Proposed Sale	27.46	1,827	50,177		Mar 26 03:21 PM
Linetsky David	SVP, Life Sciences	Mar 19 '25	Sale	27.88	88	2,454	8,724	Mar 20 05:01 PM
Linetsky David	SVP, Life Sciences	Mar 18 '25	Sale	26.95	39	1,051	8,812	Mar 20 05:01 PM
Hoffman Allison C	General Counsel & Secretary	Mar 17 '25	Sale	25.32	3,496	88,519	139,134	Mar 19 05:20 PM
Linetsky David	Member of immediate family of	Mar 19 '25	Proposed Sale	27.89	88	2,454		Mar 19 03:32 PM
Linetsky David	Member of immediate family of	Mar 18 '25	Proposed Sale	26.95	39	1,051		Mar 18 03:15 PM
Hoffman Allison C	Officer	Mar 17 '25	Proposed Sale	25.32	3,496	88,519		Mar 17 09:54 AM
Roberts Evan	Chief Operating Officer	Feb 18 '25	Sale	30.06	3,519	105,764	741,197	Feb 20 04:49 PM
Roberts Evan	Chief Operating Officer	Feb 19 '25	Sale	30.00	177	5,310	741,020	Feb 20 04:49 PM
Gandhi Balaji	Chief Financial Officer	Feb 18 '25	Sale	30.04	5,771	173,377	105,514	Feb 20 04:48 PM
Gandhi Balaji	Chief Financial Officer	Feb 19 '25	Sale	30.00	96	2,880	105,418	Feb 20 04:48 PM
Hoffman Allison C	General Counsel & Secretary	Feb 18 '25	Sale	29.72	3,496	103,901	142,630	Feb 20 04:47 PM
Gandhi Balaji	Officer	Feb 19 '25	Proposed Sale	30.00	96	2,880		Feb 19 04:41 PM
Roberts Evan	Officer	Feb 19 '25	Proposed Sale	30.00	177	5,310		Feb 19 04:01 PM
Roberts Evan	Chief Operating Officer	Feb 13 '25	Sale	30.00	16,005	480,152	748,302	Feb 18 04:38 PM
Roberts Evan	Chief Operating Officer	Feb 14 '25	Sale	30.13	3,586	108,039	744,716	Feb 18 04:38 PM
Gandhi Balaji	Chief Financial Officer	Feb 13 '25	Sale	30.00	28,759	862,770	116,174	Feb 18 04:36 PM
Gandhi Balaji	Chief Financial Officer	Feb 14 '25	Sale	30.09	4,889	147,088	111,285	Feb 18 04:36 PM
Linetsky David	SVP, Life Sciences	Feb 13 '25	Sale	29.70	11,616	345,001	218,135	Feb 18 04:35 PM
Gandhi Balaji	Officer	Feb 18 '25	Proposed Sale	30.04	5,771	173,377		Feb 18 04:33 PM
Roberts Evan	Officer	Feb 18 '25	Proposed Sale	30.06	3,519	105,764		Feb 18 04:15 PM
Hoffman Allison C	Officer	Feb 18 '25	Proposed Sale	29.72	3,496	103,901		Feb 18 10:16 AM
Gandhi Balaji	Officer	Feb 14 '25	Proposed Sale	30.09	4,889	147,089		Feb 14 04:31 PM
Roberts Evan	Officer	Feb 14 '25	Proposed Sale	30.13	3,586	108,039		Feb 14 04:26 PM
Gandhi Balaji	Officer	Feb 13 '25	Proposed Sale	30.00	28,759	862,770		Feb 13 05:17 PM
Roberts Evan	Officer	Feb 13 '25	Proposed Sale	30.00	16,005	480,152		Feb 13 04:58 PM
Linetsky David	Officer	Feb 13 '25	Proposed Sale	29.70	11,616	345,001		Feb 13 04:24 PM
Linetsky David	SVP, Life Sciences	Feb 07 '25	Sale	29.52	300	8,857	229,751	Feb 11 06:16 PM
Linetsky David	SVP, Life Sciences	Feb 05 '25	Sale	29.50	720	21,241	230,051	Feb 07 04:51 PM
Linetsky David	Officer	Feb 07 '25	Proposed Sale	29.52	300	8,857		Feb 07 04:28 PM
Linetsky David	Officer	Feb 05 '25	Proposed Sale	29.50	720	21,241		Feb 05 04:13 PM
Linetsky David	SVP, Life Sciences	Jan 29 '25	Sale	29.68	500	14,841	230,771	Jan 31 04:23 PM
Gandhi Balaji	Chief Financial Officer	Jan 27 '25	Sale	27.48	4,813	132,244	144,933	Jan 29 04:52 PM
Hoffman Allison C	General Counsel & Secretary	Jan 27 '25	Sale	27.48	6,556	180,135	152,361	Jan 29 04:50 PM
Hoffman Allison C	General Counsel & Secretary	Jan 28 '25	Sale	28.50	6,235	177,698	146,126	Jan 29 04:50 PM

Dollar change -0.49
Percentage change -5.56	%

TDOC Teladoc Health Inc daily Stock Chart

Peers: AMWL DOCS TVRD HIMS GDRX CLOV OSCR ACHC MD RMTI

| Held by: IWM VTI VB VXF VBK IWN DFAT FNDA SCHA VTWO

Index	RUT	P/E	-	EPS (ttm)	-5.93	Insider Own	1.11%	Shs Outstand	175.34M	Perf Week	0.36%
Market Cap	1.46B	Forward P/E	-	EPS next Y	-0.90	Insider Trans	-5.76%	Shs Float	173.50M	Perf Month	12.43%
Enterprise Value	1.85B	PEG	-	EPS next Q	-0.26	Inst Own	73.86%	Short Float	14.17%	Perf Quarter	5.58%
Income	-1012.37M	P/S	0.57	EPS this Y	80.40%	Inst Trans	4.05%	Short Ratio	3.93	Perf Half Y	-16.72%
Sales	2.55B	P/B	1.02	EPS next Y	21.94%	ROA	-26.07%	Short Interest	24.59M	Perf YTD	-8.47%
Book/sh	8.14	P/C	1.22	EPS next 5Y	45.59%	ROE	-54.49%	52W High	15.21 -45.30%	Perf Year	-9.07%
Cash/sh	6.80	P/FCF	5.06	EPS past 3/5Y	-29.04% -33.66%	ROIC	-41.27%	52W Low	6.35 31.02%	Perf 3Y	-78.56%
Dividend Est.	-	EV/EBITDA	9.97	Sales past 3/5Y	8.13% 35.95%	Gross Margin	56.24%	Volatility	4.72% 5.69%	Perf 5Y	-96.18%
Dividend TTM	-	EV/Sales	0.73	EPS Y/Y TTM	-322.03%	Oper. Margin	-7.31%	ATR (14)	0.43	Perf 10Y	-70.29%
Dividend Ex-Date	-	Quick Ratio	1.61	Sales Y/Y TTM	-2.54%	Profit Margin	-39.66%	RSI (14)	55.85	Recom	2.60
Dividend Gr. 3/5Y	- -	Current Ratio	1.65	EPS Q/Q	-9.40%	SMA20	5.02%	Beta	1.78	Target Price	8.86
Payout	-	Debt/Eq	1.11	Sales Q/Q	-2.59%	SMA50	11.68%	Rel Volume	1.05	Prev Close	8.81
Employees	5500	LT Debt/Eq	0.72	Earnings	Apr 30 AMC	SMA200	-7.25%	Avg Volume	6.26M	Price	8.32
IPO	Jul 01, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	-54.74% 1.64%	Trades		Volume	6,591,245	Change	-5.56%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-15-24	Initiated	Goldman	Buy	$14
Sep-17-24	Reiterated	Jefferies	Hold	$8 → $10
Feb-29-24	Initiated	Cantor Fitzgerald	Overweight	$22
Feb-26-24	Initiated	Leerink Partners	Market Perform	$17
Jan-17-24	Downgrade	DA Davidson	Buy → Neutral	$33 → $22
Jan-03-24	Initiated	Barclays	Overweight	$26
Apr-12-23	Initiated	Stephens	Equal-Weight	$25
Feb-23-23	Upgrade	SVB Securities	Market Perform → Outperform	$34
Oct-24-22	Upgrade	Guggenheim	Sell → Neutral
Sep-16-22	Initiated	KeyBanc Capital Markets	Sector Weight
Sep-07-22	Initiated	Truist	Hold	$35
Aug-17-22	Downgrade	Guggenheim	Neutral → Sell	$25
Aug-12-22	Initiated	DA Davidson	Buy	$45
Aug-02-22	Downgrade	Cowen	Outperform → Market Perform	$58 → $34
Aug-02-22	Downgrade	Berenberg	Buy → Hold	$35
Jul-28-22	Downgrade	Needham	Buy → Hold
Jul-28-22	Downgrade	Goldman	Buy → Neutral	$55 → $36
Jul-06-22	Reiterated	BofA Securities	Neutral	$36 → $42
May-05-22	Downgrade	Argus	Buy → Hold
Apr-28-22	Downgrade	William Blair	Outperform → Mkt Perform

Show Previous Ratings

Jul-11-25 06:15PM	Teladoc (TDOC) Dips More Than Broader Market: What You Should Know (Zacks) -5.56%
11:27AM	BofA Remains a Hold on Teladoc Health (TDOC), Sets a PT of $8.75 (Insider Monkey)
Jul-09-25 02:25PM	Teladoc (TDOC) Stock Trades Up, Here Is Why (StockStory)
Jul-03-25 12:01PM	Hims & Hers Enhances Healthcare Through AI-Driven Personalization (Zacks)
10:33AM	OPRX Shares Rise 69.3% in 3 Months: Time to Bet on the Stock? (Zacks)
06:15PM	Loading…
Jul-01-25 06:15PM	Teladoc (TDOC) Sees a More Significant Dip Than Broader Market: Some Facts to Know (Zacks)
Jun-25-25 08:30AM	5 Insightful Analyst Questions From Teladoc's Q1 Earnings Call (StockStory) -5.37%
Jun-24-25 04:43PM	Teladoc Stock Is a Coiled Spring That Could Surge Higher. Should You Buy TDOC Here? (Barchart)
02:07PM	Teladoc (TDOC) Moves 14.4% Higher: Will This Strength Last? (Zacks)
Jun-23-25 04:44PM	Teladoc (TDOC) Stock Trades Up, Here Is Why (StockStory) +14.35%
11:07AM	Teladoc Health, Inc. (TDOC): A Bull Case Theory (Insider Monkey)
Jun-19-25 12:09PM	Hims & Hers Stock Jumps 85.1% in 3 Months: Is It a Buy Now? (Zacks)
Jun-16-25 06:15PM	Teladoc (TDOC) Rises Higher Than Market: Key Facts (Zacks)
Jun-13-25 06:30AM	What are the top holdings of Cathie Wood's ARK Innovation ETF? (Yahoo Finance Video)
Jun-12-25 05:45AM	M&A to play important role at Teladoc: CEO (Healthcare Dive)
06:15PM	Loading…
Jun-09-25 06:15PM	Teladoc (TDOC) Outperforms Broader Market: What You Need to Know (Zacks)
Jun-05-25 12:20PM	HIMS' Buyouts Fuel International Expansion & Digital Health Innovation (Zacks)
11:44AM	Doximity Declines 4.4% in a Month: How to Play the Stock Now? (Zacks)
08:00AM	Teladoc Health to Participate in Upcoming Investor Conference (GlobeNewswire)
Jun-04-25 08:41AM	Doximity Rides on Telehealth Demand: Will This Drive Sales Further? (Zacks)
Jun-03-25 04:30PM	Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 (GlobeNewswire)
Jun-02-25 12:40AM	3 of Wall Street's Favorite Stocks Walking a Fine Line (StockStory)
May-30-25 11:31AM	Why Is Teladoc (TDOC) Down 0.1% Since Last Earnings Report? (Zacks)
May-23-25 12:33AM	1 Russell 2000 Stock for Long-Term Investors and 2 to Be Wary Of (StockStory)
May-21-25 04:19PM	Hinge Health, MNTN IPOs Test Strength of US Listing Rebound (Bloomberg) -5.04%
May-20-25 07:33AM	From Retina Scans to Cancer Trials, AI Is Taking Over the Exam Room (PR Newswire)
May-19-25 12:38AM	3 Value Stocks in Hot Water (StockStory)
May-16-25 10:25AM	Hims & Hers Stock Declines 3.1% in 3 Months: Is it a Buy Now? (Zacks)
05:30AM	1 Beaten-Down Stock to Buy Right Now, and 1 to Avoid (Motley Fool)
May-08-25 11:39AM	TDOC Q1 Loss Narrower Than Estimates on Strong Integrated Care Unit (Zacks)
10:12AM	Loading…
10:12AM	Teladoc Health, Inc. (TDOC): Among the Best Growth Stocks Under $10 to Buy Right Now (Insider Monkey)
May-06-25 09:45AM	Tech That Listens, Learns, and Diagnoses: AI's Breakout Moment in Healthcare (PR Newswire) -5.17%
May-03-25 10:00AM	Teladoc Health: No Real Rescue In Sight (Seeking Alpha)
May-02-25 09:30PM	Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 (GlobeNewswire)
May-01-25 09:05AM	Q1 2025 Teladoc Health Inc Earnings Call (Thomson Reuters StreetEvents)
05:59AM	Teladoc acquires mental health firm UpLift as BetterHelp earnings slide (Healthcare Dive)
03:17AM	Teladoc Health Inc (TDOC) Q1 2025 Earnings Call Highlights: Navigating Challenges and Seizing ... (GuruFocus.com)
Apr-30-25 09:42PM	Teladoc Health, Inc. (TDOC) Q1 2025 Earnings Call Transcript (Seeking Alpha)
06:00PM	Teladoc (TDOC) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks)
05:25PM	Teladoc (TDOC) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:24PM	Teladoc: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Teladoc Health Reports First Quarter 2025 Results (GlobeNewswire)
04:01PM	Teladoc Health Acquires UpLift, Expanding Consumer Access to Mental Health Care Services Through Covered Benefits (GlobeNewswire)
12:43PM	Hims & Hers vs. Teladoc: Which Telehealth Stock Is the Better Buy Now? (Zacks)
Apr-29-25 03:08AM	Teladoc (TDOC) Reports Earnings Tomorrow: What To Expect (StockStory)
Apr-28-25 09:16AM	Unveiling Teladoc (TDOC) Q1 Outlook: Wall Street Estimates for Key Metrics (Zacks)
05:03AM	Online Marketplace Stocks Q4 Teardown: CarGurus (NASDAQ:CARG) Vs The Rest (StockStory)
Apr-25-25 06:15PM	Teladoc (TDOC) Stock Sinks As Market Gains: Here's Why (Zacks)
Apr-21-25 05:29PM	Is Teladoc Health (TDOC) the Best Telehealth Stock to Buy Now? (Insider Monkey) +5.99%
Apr-16-25 06:00PM	Teladoc Health to Announce First Quarter 2025 Financial Results (GlobeNewswire)
11:48AM	Teladoc: Back In The Doldrums After Another Tough Year (Rating Downgrade) (Seeking Alpha)
08:43AM	Hims & Hers Stock Gains 5.8% in 3 Months: Here's How to Play it (Zacks)
Apr-12-25 02:05PM	2 Beaten-Down Stocks to Avoid in the Tariff-Fueled Correction (Motley Fool)
Apr-11-25 01:15PM	Buy Certara After The FDA Announcement (Seeking Alpha)
Apr-08-25 06:15PM	Teladoc (TDOC) Stock Moves -0.97%: What You Should Know (Zacks) +10.06%
06:00AM	Teladoc Health Introduces Next Generation Cardiometabolic Health Program (GlobeNewswire)
Apr-02-25 06:15PM	Teladoc (TDOC) Gains But Lags Market: What You Should Know (Zacks)
Apr-01-25 04:15PM	Hims Stock Jumps After Adding Eli Lilly's Obesity Drug To Its Platform (Investor's Business Daily)
04:02PM	Hims Stock Jumps After Inking Deal To Sell Eli Lilly's Obesity Drug, Zepbound (Investor's Business Daily)
02:30PM	Hims Stock Rockets After Inking Deal To Sell Eli Lilly's Obesity Drug, Zepbound (Investor's Business Daily)
Mar-30-25 09:30AM	Should Investors Buy These 2 Beaten-Down Artificial Intelligence (AI) Healthcare Stocks? (Motley Fool)
Mar-28-25 11:30AM	Why Is Teladoc (TDOC) Down 9.9% Since Last Earnings Report? (Zacks) -5.49%
Mar-26-25 06:15PM	Teladoc (TDOC) Flat As Market Sinks: What You Should Know (Zacks)
09:15AM	Teladoc's Meltdown May Not Be Over Yet - Minimal Growth Opportunities (SeekingAlpha)
05:14AM	Teladoc (TDOC): Buy, Sell, or Hold Post Q4 Earnings? (StockStory)
Mar-25-25 08:45AM	AI Influence on Medical Diagnostics Generating Billion Dollar Revenues While Growing Adoption Reduces Healthcare Costs (GlobeNewswire)
Mar-19-25 06:15PM	Teladoc (TDOC) Exceeds Market Returns: Some Facts to Consider (Zacks)
Mar-18-25 01:49PM	Teladoc Health (TDOC): Among the Best Diabetes Stocks to Buy According to Billionaires (Insider Monkey) -5.41%
05:05AM	Spotting Winners: Teladoc (NYSE:TDOC) And Online Marketplace Stocks In Q4 (StockStory)
Mar-17-25 04:13AM	Does Teladoc's $65 Million Acquisition of Catapult Health Make the Stock a Buy? (Motley Fool)
Mar-13-25 09:02AM	Carrum Health Selected by Teladoc Health as Centers of Excellence Partner (PR Newswire)
05:04AM	A Look Back at Online Marketplace Stocks Q4 Earnings: Shutterstock (NYSE:SSTK) Vs The Rest Of The Pack (StockStory)
Mar-12-25 09:00AM	Cylinder joins Teladoc Healths Connected Care Program to expand access to virtual digestive care (GlobeNewswire)
Mar-11-25 06:15PM	Teladoc (TDOC) Advances While Market Declines: Some Information for Investors (Zacks)
08:00AM	Teladoc Health Expands Connected Care Partnerships (GlobeNewswire)
05:04AM	Q4 Rundown: The RealReal (NASDAQ:REAL) Vs Other Online Marketplace Stocks (StockStory)
05:01AM	Q4 Online Marketplace Earnings: MercadoLibre (NASDAQ:MELI) Earns Top Marks (StockStory)
Mar-10-25 05:05AM	Q4 Earnings Highs And Lows: EverQuote (NASDAQ:EVER) Vs The Rest Of The Online Marketplace Stocks (StockStory)
Mar-07-25 08:02AM	3 Small-Cap Stocks in the Doghouse (StockStory)
Mar-06-25 03:52PM	Teladoc stock jumps on GLP-1 deal with Eli Lilly (Yahoo Finance Video)
02:27PM	Teladoc partners with Eli Lilly, Burlington stock rises: Market Minute (Yahoo Finance Video)
11:29AM	Teladoc Health Partners With Eli Liily's LillyDirect to Expand Access to Zepbound For Weight Loss (Benzinga)
08:31AM	Teladoc Health Adds GLP-1 Self-Pay Option to Comprehensive Weight Care (GlobeNewswire)
Mar-05-25 06:00PM	Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 (GlobeNewswire)
Mar-04-25 08:00AM	Teladoc Health Connects Digital & Community Providers to Deliver Next Generation of Virtually Integrated Care (GlobeNewswire)
Mar-03-25 06:15PM	Teladoc (TDOC) Stock Moves -1.36%: What You Should Know (Zacks)
Feb-28-25 10:27AM	Teladoc Health, Inc. (TDOC): A Bull Case Theory (Insider Monkey)
Feb-27-25 04:29PM	These Stocks Moved the Most Today: Nvidia, Super Micro, Snowflake, Moderna, Tesla, Salesforce, Vistra, and More (Barrons.com) -13.56%
03:06PM	Why Teladoc (TDOC) Stock Is Trading Lower Today (StockStory)
02:57PM	Why Teladoc Stock Is Plummeting Today (Motley Fool)
12:59PM	Teladoc Health, Virgin Galactic: Trending Tickers (Yahoo Finance Video)
11:55AM	These Stocks Are Moving the Most Today: Nvidia, Super Micro, Snowflake, Moderna, Tesla, Salesforce, Vistra, and More (Barrons.com)
07:21AM	Q4 2024 Teladoc Health Inc Earnings Call (Thomson Reuters StreetEvents)
06:44AM	Teladoc Health Shares Plunge 15% After-Hours as Q4 Loss Widens, Revenue Declines (GuruFocus.com)
06:02AM	Teladoc posts $1B loss in 2024 as BetterHelp lags (Healthcare Dive)
02:21AM	Teladoc Health Inc (TDOC) Q4 2024 Earnings Call Highlights: Navigating Growth and Challenges (GuruFocus.com)
Feb-26-25 11:00PM	Teladoc Health (TDOC) Q4 2024 Earnings Call Transcript (Motley Fool)
06:30PM	Here's What Key Metrics Tell Us About Teladoc (TDOC) Q4 Earnings (Zacks)
06:15PM	Teladoc (TDOC) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
05:12PM	Teladoc: Q4 Earnings Snapshot (Associated Press Finance)

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Rodrigues Fernando M.	President of BetterHelp	Jun 03 '25	Sale	6.91	4,174	28,842	0	Jun 03 05:37 PM
Rodrigues Fernando M.	President of BetterHelp	Jun 02 '25	Sale	6.86	2,358	16,176	4,174	Jun 03 05:37 PM
Vandervoort Adam C	CHIEF LEGAL OFFICER, SECRETARY	Jun 02 '25	Sale	6.86	5,808	39,843	69,773	Jun 03 05:37 PM
Bliss Kelly	President, U.S. Group Health	Jun 02 '25	Sale	6.86	4,653	31,920	50,266	Jun 03 05:36 PM
Murthy Mala	CHIEF FINANCIAL OFFICER	Jun 02 '25	Sale	6.86	13,856	95,052	132,443	Jun 03 05:36 PM
Nueno Carlos	President, International	Jun 02 '25	Sale	6.86	3,958	27,152	17,645	Jun 03 05:36 PM
Rodrigues Fernando M.	Officer	Jun 03 '25	Proposed Sale	6.91	4,174	28,842		Jun 03 10:53 AM
Murthy Mala	Officer	Jun 02 '25	Proposed Sale	6.86	13,856	95,052		Jun 02 03:46 PM
Rodrigues Fernando M.	Officer	Jun 02 '25	Proposed Sale	6.86	2,358	16,176		Jun 02 03:45 PM
Vandervoort Adam C	Officer	Jun 02 '25	Proposed Sale	6.86	5,808	39,843		Jun 02 03:44 PM
Bliss Kelly	Officer	Jun 02 '25	Proposed Sale	6.86	4,653	31,920		Jun 02 03:43 PM
Nueno Carlos	Officer	Jun 02 '25	Proposed Sale	6.86	3,958	27,152		Jun 02 03:38 PM
Murthy Mala	CHIEF FINANCIAL OFFICER	Apr 07 '25	Sale	6.81	7,494	51,012	121,467	Apr 08 04:23 PM
Murthy Mala	Officer	Apr 07 '25	Proposed Sale	6.81	7,494	51,012		Apr 07 05:15 PM
Murthy Mala	CHIEF FINANCIAL OFFICER	Mar 20 '25	Sale	8.42	20,586	173,416	116,309	Mar 21 04:20 PM
Vandervoort Adam C	CHIEF LEGAL OFFICER, SECRETARY	Mar 20 '25	Sale	8.42	11,011	92,757	64,308	Mar 21 04:20 PM
Rodrigues Fernando M.	President of BetterHelp	Mar 21 '25	Sale	8.00	2,663	21,304	0	Mar 21 04:19 PM
Rodrigues Fernando M.	President of BetterHelp	Mar 20 '25	Sale	8.42	1,503	12,661	2,663	Mar 21 04:19 PM
Bliss Kelly	President, U.S. Group Health	Mar 20 '25	Sale	8.42	9,470	79,775	45,384	Mar 21 04:19 PM
Nueno Carlos	President, International	Mar 20 '25	Sale	8.42	8,266	69,633	12,891	Mar 21 04:19 PM
Rodrigues Fernando M.	Officer	Mar 21 '25	Proposed Sale	8.00	2,663	21,304		Mar 21 10:16 AM
Rodrigues Fernando M.	Officer	Mar 20 '25	Proposed Sale	8.42	1,503	12,661		Mar 20 03:25 PM
Bliss Kelly	Officer	Mar 20 '25	Proposed Sale	8.42	9,470	79,773		Mar 20 03:13 PM
Murthy Mala	Officer	Mar 20 '25	Proposed Sale	8.42	20,586	173,412		Mar 20 03:12 PM
Vandervoort Adam C	Officer	Mar 20 '25	Proposed Sale	8.42	11,011	92,754		Mar 20 03:10 PM
Nueno Carlos	Officer	Mar 20 '25	Proposed Sale	8.42	8,266	69,631		Mar 20 03:09 PM
Rodrigues Fernando M.	President of BetterHelp	Mar 05 '25	Sale	9.20	3,558	32,734	0	Mar 06 04:04 PM
Rodrigues Fernando M.	Officer	Mar 05 '25	Proposed Sale	9.20	3,558	32,734		Mar 05 09:44 AM
Rodrigues Fernando M.	President of BetterHelp	Mar 03 '25	Sale	9.68	1,933	18,719	3,558	Mar 04 04:07 PM
Murthy Mala	CHIEF FINANCIAL OFFICER	Mar 03 '25	Sale	9.68	8,630	83,573	99,962	Mar 04 04:07 PM
Nueno Carlos	President, International	Mar 03 '25	Sale	9.68	2,347	22,728	2,932	Mar 04 04:06 PM
Bliss Kelly	President, U.S. Group Health	Mar 03 '25	Sale	9.68	2,904	28,122	35,421	Mar 04 04:06 PM
Vandervoort Adam C	CHIEF LEGAL OFFICER, SECRETARY	Mar 03 '25	Sale	9.68	3,935	38,107	53,919	Mar 04 04:06 PM
Bliss Kelly	Officer	Mar 03 '25	Proposed Sale	9.68	2,904	28,124		Mar 03 04:29 PM
Murthy Mala	Officer	Mar 03 '25	Proposed Sale	9.68	8,630	83,576		Mar 03 04:22 PM
Nueno Carlos	Officer	Mar 03 '25	Proposed Sale	9.68	2,347	22,729		Mar 03 04:21 PM
Rodrigues Fernando M.	Officer	Mar 03 '25	Proposed Sale	9.68	1,933	18,720		Mar 03 04:20 PM
Vandervoort Adam C	Officer	Mar 03 '25	Proposed Sale	9.68	3,935	38,108		Mar 03 04:17 PM
Nanis Nikolaos P.	Officer	Jan 03 '25	Proposed Sale	9.33	502	4,681		Jan 03 05:31 PM
Waters Michael Willem	Officer	Dec 16 '24	Proposed Sale	10.28	4,652	47,823		Dec 16 10:46 AM
Nueno Carlos	President, International	Dec 03 '24	Sale	11.23	2,890	32,455	0	Dec 03 05:30 PM
Nueno Carlos	President, International	Dec 02 '24	Sale	11.93	2,389	28,494	2,890	Dec 03 05:30 PM
Vandervoort Adam C	CHIEF LEGAL OFFICER, SECRETARY	Dec 02 '24	Sale	11.93	4,004	47,756	50,050	Dec 03 05:29 PM
Murthy Mala	CHIEF FINANCIAL OFFICER	Dec 02 '24	Sale	11.93	8,783	104,755	92,788	Dec 03 05:28 PM
Rodrigues Fernando M.	President of BetterHelp	Dec 03 '24	Sale	11.07	14,091	156,001	0	Dec 03 05:26 PM
Rodrigues Fernando M.	President of BetterHelp	Dec 02 '24	Sale	11.93	7,873	93,901	14,091	Dec 03 05:26 PM
Bliss Kelly	President, U.S. Group Health	Dec 02 '24	Sale	11.93	2,040	24,331	32,244	Dec 03 05:20 PM
Rodrigues Fernando M.	Officer	Dec 03 '24	Proposed Sale	11.07	14,091	156,002		Dec 03 12:11 PM
Nueno Carlos	Officer	Dec 03 '24	Proposed Sale	11.23	2,890	32,455		Dec 03 11:02 AM
Raman-Tangella Vidya	Officer	Dec 03 '24	Proposed Sale	11.23	468	5,256		Dec 03 09:56 AM
Murthy Mala	Officer	Dec 02 '24	Proposed Sale	11.93	8,783	104,752		Dec 02 04:53 PM
Raman-Tangella Vidya	Officer	Dec 02 '24	Proposed Sale	11.93	1,588	18,940		Dec 02 04:49 PM
Vandervoort Adam C	Officer	Dec 02 '24	Proposed Sale	11.93	4,004	47,754		Dec 02 04:45 PM
Waters Michael Willem	Officer	Dec 02 '24	Proposed Sale	11.93	4,234	50,498		Dec 02 04:41 PM
Nanis Nikolaos P.	Officer	Dec 02 '24	Proposed Sale	11.93	4,218	50,307		Dec 02 04:11 PM
Bliss Kelly	Officer	Dec 02 '24	Proposed Sale	11.93	2,040	24,330		Dec 02 04:08 PM
Nueno Carlos	Officer	Dec 02 '24	Proposed Sale	11.93	2,389	28,493		Dec 02 04:04 PM
Rodrigues Fernando M.	Officer	Dec 02 '24	Proposed Sale	11.93	7,873	93,899		Dec 02 03:25 PM
Verstraete Stephany	Former Officer	Nov 19 '24	Proposed Sale	8.92	75,463	673,130		Nov 19 11:25 AM
Geshuri Arnnon	Former Officer	Nov 15 '24	Proposed Sale	9.21	34,456	317,512		Nov 15 03:32 PM
Geshuri Arnnon	Former Officer	Nov 12 '24	Proposed Sale	9.58	60,000	574,800		Nov 12 02:20 PM
Raman-Tangella Vidya	Officer	Nov 05 '24	Proposed Sale	8.88	1,537	13,649		Nov 05 10:08 AM
Waters Michael Willem	Officer	Nov 04 '24	Proposed Sale	8.67	6,097	52,845		Nov 04 04:50 PM
Geshuri Arnnon	Former Officer	Nov 04 '24	Proposed Sale	8.87	160,278	1,421,691		Nov 04 04:21 PM
Raman-Tangella Vidya	Officer	Nov 04 '24	Proposed Sale	8.67	4,776	41,395		Nov 04 03:55 PM
Verstraete Stephany	Former Officer	Oct 31 '24	Proposed Sale	9.23	16,992	156,755		Oct 31 03:13 PM
Trencher Daniel	Former Officer	Oct 29 '24	Proposed Sale	9.15	18,000	164,739		Oct 29 01:17 PM
Turitz Andrew	Former Officer	Oct 11 '24	Proposed Sale	9.49	38,983	370,102		Oct 11 03:27 PM
Kornwasser Laizer	Former Officer	Oct 09 '24	Proposed Sale	8.90	29,516	262,825		Oct 09 03:16 PM
Trencher Daniel	Former Officer	Oct 08 '24	Proposed Sale	8.58	8,343	71,612		Oct 08 03:22 PM
Turitz Andrew	Former Officer	Oct 08 '24	Proposed Sale	8.58	7,398	63,501		Oct 08 03:21 PM
Bliss Kelly	President, U.S. Group Health	Oct 02 '24	Sale	8.68	897	7,783	28,203	Oct 02 04:13 PM
Nanis Nikolaos P.	Officer	Oct 02 '24	Proposed Sale	8.68	454	3,939		Oct 02 03:20 PM
Bliss Kelly	Officer	Oct 02 '24	Proposed Sale	8.68	897	7,783		Oct 02 03:19 PM
Raman-Tangella Vidya	Officer	Oct 02 '24	Proposed Sale	8.73	14,737	128,654		Oct 02 10:22 AM
Trencher Daniel	Former Officer	Sep 16 '24	Proposed Sale	8.21	9,960	81,773		Sep 16 03:35 PM
MCKINLEY THOMAS	Director	Sep 12 '24	Buy	7.69	4,000	30,756	39,077	Sep 13 05:14 PM
Turitz Andrew	EVP, CORPORATE DEVELOPMENT	Sep 04 '24	Sale	7.26	20,773	150,812	20,773	Sep 05 04:05 PM
Raman-Tangella Vidya	CHIEF MEDICAL OFFICER	Sep 04 '24	Sale	7.26	468	3,398	33,665	Sep 05 04:05 PM
Geshuri Arnnon	CHIEF PEOPLE OFFICER	Sep 03 '24	Sale	7.16	1,795	12,859	44,914	Sep 04 04:13 PM
Murthy Mala	CHIEF FINANCIAL OFFICER	Sep 03 '24	Sale	7.16	8,750	62,685	85,767	Sep 04 04:13 PM
Nanis Nikolaos P.	Chief Technology Officer	Sep 03 '24	Sale	7.16	1,033	7,400	75,410	Sep 04 04:12 PM
Vandervoort Adam C	CHIEF LEGAL OFFICER, SECRETARY	Sep 03 '24	Sale	7.16	2,817	20,181	46,250	Sep 04 04:12 PM
Verstraete Stephany	CHIEF MARKETING OFFICER	Sep 03 '24	Sale	7.16	2,083	14,923	48,843	Sep 04 04:12 PM
Cave James L.	INTERIM CAO	Sep 03 '24	Sale	7.16	555	3,976	13,808	Sep 04 04:12 PM
Trencher Daniel	CHIEF STRATEGY OFFICER	Sep 03 '24	Sale	7.16	1,777	12,730	31,465	Sep 04 04:12 PM
Waters Michael Willem	CHIEF OPERATING OFFICER	Sep 03 '24	Sale	7.16	4,218	30,218	78,309	Sep 04 04:11 PM
Turitz Andrew	EVP, CORPORATE DEVELOPMENT	Sep 03 '24	Sale	7.16	1,617	11,584	41,546	Sep 04 04:11 PM
Raman-Tangella Vidya	CHIEF MEDICAL OFFICER	Sep 03 '24	Sale	7.16	1,114	7,981	34,133	Sep 04 04:11 PM
Raman-Tangella Vidya	Officer	Sep 04 '24	Proposed Sale	7.26	468	3,398		Sep 04 10:25 AM
Turitz Andrew	Officer	Sep 04 '24	Proposed Sale	7.26	20,773	150,812		Sep 04 10:18 AM
Geshuri Arnnon	Officer	Sep 03 '24	Proposed Sale	7.16	1,795	12,859		Sep 03 04:06 PM
Nanis Nikolaos P.	Officer	Sep 03 '24	Proposed Sale	7.16	1,033	7,400		Sep 03 03:54 PM
Murthy Mala	Officer	Sep 03 '24	Proposed Sale	7.16	8,750	62,681		Sep 03 03:49 PM
Verstraete Stephany	Officer	Sep 03 '24	Proposed Sale	7.16	2,083	14,922		Sep 03 03:41 PM
Waters Michael Willem	Officer	Sep 03 '24	Proposed Sale	7.16	4,218	30,216		Sep 03 03:35 PM
Vandervoort Adam C	Officer	Sep 03 '24	Proposed Sale	7.16	2,817	20,180		Sep 03 03:32 PM
Raman-Tangella Vidya	Officer	Sep 03 '24	Proposed Sale	7.16	1,114	7,980		Sep 03 03:27 PM
Trencher Daniel	Officer	Sep 03 '24	Proposed Sale	7.16	1,777	12,730		Sep 03 03:13 PM
Turitz Andrew	Officer	Sep 03 '24	Proposed Sale	7.17	1,617	11,587		Sep 03 03:09 PM

Dollar change -2.21
Percentage change -1.96	%

JAZZ Jazz Pharmaceuticals plc daily Stock Chart

Peers: VRTX REGN BIIB INCY GILD BMRN NBIX EXEL UTHR SAGE

| Held by: IJH VTI VB VXF VBR CALF MDY IJJ SPMD DFAT

Index	-	P/E	14.87	EPS (ttm)	7.42	Insider Own	4.49%	Shs Outstand	61.62M	Perf Week	0.75%
Market Cap	6.67B	Forward P/E	5.11	EPS next Y	21.57	Insider Trans	2.59%	Shs Float	57.79M	Perf Month	-2.42%
Enterprise Value	9.52B	PEG	3.87	EPS next Q	-7.54	Inst Own	98.70%	Short Float	10.16%	Perf Quarter	0.14%
Income	482.20M	P/S	1.64	EPS this Y	-77.11%	Inst Trans	1.29%	Short Ratio	5.95	Perf Half Y	-10.01%
Sales	4.06B	P/B	1.63	EPS next Y	350.78%	ROA	4.22%	Short Interest	5.87M	Perf YTD	-10.46%
Book/sh	67.75	P/C	2.59	EPS next 5Y	3.84%	ROE	12.25%	52W High	148.06 -25.52%	Perf Year	9.65%
Cash/sh	42.50	P/FCF	4.41	EPS past 3/5Y	- -1.00%	ROIC	5.05%	52W Low	95.49 15.48%	Perf 3Y	-31.27%
Dividend Est.	-	EV/EBITDA	7.58	Sales past 3/5Y	9.56% 13.48%	Gross Margin	73.41%	Volatility	2.59% 2.46%	Perf 5Y	-0.84%
Dividend TTM	-	EV/Sales	2.34	EPS Y/Y TTM	49.58%	Oper. Margin	14.63%	ATR (14)	2.99	Perf 10Y	-37.83%
Dividend Ex-Date	-	Quick Ratio	2.97	Sales Y/Y TTM	5.76%	Profit Margin	11.86%	RSI (14)	52.75	Recom	1.16
Dividend Gr. 3/5Y	- -	Current Ratio	3.38	EPS Q/Q	-549.10%	SMA20	1.46%	Beta	0.33	Target Price	182.47
Payout	0.00%	Debt/Eq	1.30	Sales Q/Q	-0.46%	SMA50	1.28%	Rel Volume	0.41	Prev Close	112.48
Employees	2800	LT Debt/Eq	1.29	Earnings	May 06 AMC	SMA200	-6.72%	Avg Volume	986.06K	Price	110.27
IPO	Jun 01, 2007	Option/Short	Yes / Yes	EPS/Sales Surpr.	-63.93% -8.74%	Trades		Volume	404,730	Change	-1.96%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-07-25	Upgrade	UBS	Neutral → Buy	$145 → $179
Feb-26-25	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Feb-13-25	Upgrade	Wells Fargo	Equal Weight → Overweight	$130 → $170
Dec-12-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$140 → $175
Jun-05-24	Initiated	Goldman	Buy	$169
Jan-03-24	Initiated	Robert W. Baird	Outperform	$160
Nov-27-23	Downgrade	UBS	Buy → Neutral	$170 → $135
Sep-29-23	Initiated	Raymond James	Mkt Perform
Jun-12-23	Resumed	Wells Fargo	Equal Weight	$184 → $140
Dec-09-22	Upgrade	Goldman	Neutral → Buy	$192 → $190
Jun-14-22	Initiated	UBS	Buy	$194
Apr-06-22	Downgrade	Goldman	Buy → Neutral	$202 → $196
Nov-19-21	Resumed	Goldman	Buy	$198
Oct-07-21	Resumed	Jefferies	Buy	$172
Oct-05-21	Initiated	Citigroup	Buy	$200
Sep-23-21	Initiated	Needham	Buy	$220
May-19-21	Resumed	JP Morgan	Overweight	$183 → $206
Apr-07-21	Resumed	RBC Capital Mkts	Outperform	$186
Feb-05-21	Reiterated	H.C. Wainwright	Buy	$195 → $207
Feb-03-21	Upgrade	Piper Sandler	Neutral → Overweight	$150 → $175

Show Previous Ratings

Jul-11-25 07:51AM	Jazz names new CEO; Ultragenyx, Mereo shares slide on trial update (BioPharma Dive)
Jul-10-25 08:00AM	Acadia Emerges From Behind The Scenes With A Potential $12 Billion Opportunity (Investor's Business Daily)
07:30AM	Jazz Pharmaceuticals Names Renee Gala as President and Chief Executive Officer (PR Newswire)
Jul-08-25 12:05AM	3 Reasons to Sell JAZZ and 1 Stock to Buy Instead (StockStory)
Jul-07-25 01:00AM	Nuevocor Strengthens Board with Appointment of Thierry Abribat (PR Newswire)
04:00AM	Loading…
Jul-06-25 04:00AM	Jazz Pharmaceuticals' Ziihera Receives Conditional European Approval for Advanced Biliary Tract Cancer (Insider Monkey)
Jul-04-25 07:48AM	Here's Why Harmony Biosciences Is an Unconventional Cannabis Investment (Zacks)
Jul-02-25 05:21AM	EC approves Jazz Pharmaceuticals Ziihera for biliary tract cancer (Pharmaceutical Technology)
02:46AM	Jazz Pharmaceuticals Gets UBS Buy Rating After Strong ASCO 2025 Trial Results (Insider Monkey)
Jul-01-25 08:31AM	Jazz Pharmaceuticals Receives European Commission Marketing Authorization for Ziihera (zanidatamab) for the Treatment of Advanced HER2-Positive Biliary Tract Cancer (PR Newswire)
Jun-27-25 05:22AM	The 5 Most Interesting Analyst Questions From Jazz Pharmaceuticals's Q1 Earnings Call (StockStory)
Jun-11-25 07:59PM	Jazz Pharmaceuticals Releases Unexpected Phase 4 Results Highlighting Xywav (Insider Monkey)
Jun-10-25 07:05AM	Zepzelca (lurbinectedin) and Atezolizumab (Tecentriq) Combination Granted U.S. FDA Priority Review for First-Line Maintenance Treatment of Extensive-Stage Small Cell Lung Cancer (PR Newswire)
Jun-09-25 06:00PM	Jazz Pharmaceuticals Presents Late-Breaking Phase 4 Data Showcasing Xywav (calcium, magnesium, potassium, and sodium oxybates) Oral Solution Treatment Outcomes in Narcolepsy at SLEEP 2025 (PR Newswire)
Jun-05-25 11:30AM	Why Is Jazz (JAZZ) Up 7.9% Since Last Earnings Report? (Zacks)
04:05PM	Loading…
Jun-02-25 04:05PM	Jazz Pharmaceuticals Announces Zepzelca (lurbinectedin) and Atezolizumab (Tecentriq) Combination Significantly Improves Survival as First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer (PR Newswire)
12:35PM	Jazz Pharmaceuticals Reports Clinically Meaningful Long-Term Median Overall Survival Data for Ziihera (zanidatamab-hrii) in First-Line HER2-Positive Metastatic Gastroesophageal Adenocarcinoma at ASCO 2025 (PR Newswire)
May-29-25 07:30AM	Jazz Pharmaceuticals to Present Expansive Research Demonstrating Comprehensive Treatment Benefits of Xywav (calcium, magnesium, potassium, and sodium oxybates) in Sleep Conditions and Associated Comorbidities at SLEEP 2025 (PR Newswire)
May-23-25 06:02AM	Insiders Pour Millions into These 3 Stocks Heres Why They Draw Plaudits Across the Board (TipRanks)
May-21-25 04:30PM	Jazz Pharmaceuticals to Participate in Upcoming June Investor Conferences (PR Newswire)
May-19-25 09:53AM	JAZZ Q1 Earnings Call: Revenue and Profit Miss, Product Pipeline Drives Outlook (StockStory)
May-13-25 09:16AM	Unlocking Jazz (JAZZ) International Revenues: Trends, Surprises, and Prospects (Zacks)
May-10-25 11:55AM	Biotech Alert: Searches spiking for these stocks today (TipRanks)
May-09-25 08:51AM	Pharma Stock Roundup: NVO & JAZZ's Q1 Results, AZN's Pipeline Update (Zacks)
May-08-25 06:36PM	Analyst Report: Jazz Pharmaceuticals plc (Morningstar Research)
07:20AM	Cannabis Stock Tilray Brands Loses 19% in a Month: Time to Sell or Hold? (Zacks)
May-07-25 07:13PM	Analyst Report: Jazz Pharmaceuticals plc (Morningstar Research) -8.75%
11:55AM	JAZZ Misses Q1 Earnings & Sales Estimates, Cuts '25 EPS Outlook (Zacks)
11:00AM	Appeals court reverses-in-part, vacates-in part ruling in Avadel-Jazz fight (TipRanks)
08:33AM	Jazz Pharmaceuticals (JAZZ): Among Billionaire Ray Dalio's Bridgewater's Stock Picks with Huge Upside Potential (Insider Monkey)
03:19AM	Loading…
03:19AM	Jazz Pharmaceuticals PLC (JAZZ) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... (GuruFocus.com)
May-06-25 11:06PM	Jazz Pharmaceuticals plc (JAZZ) Q1 2025 Earnings Call Transcript (Seeking Alpha) -5.94%
06:30PM	Here's What Key Metrics Tell Us About Jazz (JAZZ) Q1 Earnings (Zacks)
05:20PM	Jazz Pharmaceuticals (JAZZ) Q1 Earnings and Revenues Lag Estimates (Zacks)
04:05PM	Jazz Pharmaceuticals Announces First Quarter 2025 Financial Results and Updates 2025 Financial Guidance (PR Newswire)
09:39AM	AXSM Q1 Loss Narrower Than Expected, Auvelity Drives Revenues Y/Y (Zacks)
May-05-25 09:40AM	Here's Why Jazz Pharmaceuticals (JAZZ) is a Strong Value Stock (Zacks)
May-02-25 07:41PM	Analyst Report: Jazz Pharmaceuticals plc (Morningstar Research)
May-01-25 10:01AM	Illumina (ILMN) Earnings Expected to Grow: Should You Buy? (Zacks)
Apr-30-25 04:15PM	Jazz Pharmaceuticals to Participate in the BofA Securities 2025 Healthcare Conference (PR Newswire)
07:18AM	Buy, Sell or Hold JAZZ Stock? Key Tips Ahead of Q1 Earnings (Zacks)
Apr-29-25 09:30PM	Franklin Convertible Securities Fund Q1 2025 Commentary (Seeking Alpha)
10:01AM	Jazz Pharmaceuticals (JAZZ) Earnings Expected to Grow: Should You Buy? (Zacks)
08:14AM	3 Unconventional Cannabis Stocks to Watch in 2025 (Zacks)
Apr-28-25 05:33PM	Zymeworks: A Strong Buy With Newly-Approved Cancer Drug, Excellent Financials, And Expansive Pipeline (Seeking Alpha)
05:05AM	3 Reasons to Sell JAZZ and 1 Stock to Buy Instead (StockStory)
Apr-25-25 11:27AM	Jazz Pharmaceuticals Receives CHMP Positive Opinion for Zanidatamab for the Treatment of Advanced HER2-Positive Biliary Tract Cancer (PR Newswire)
Apr-23-25 04:15PM	Jazz Pharmaceuticals Showcases Transformative Data at ASCO 2025, Highlighting Advances in Small Cell Lung Cancer, HER2+ Gastroesophageal Cancer and Diffuse Glioma (PR Newswire)
11:17AM	Buy 5 High ROE Stocks as Markets Break Tariff-Induced Losing Streak (Zacks)
Apr-22-25 04:15PM	Jazz Pharmaceuticals to Report First Quarter Financial Results on May 6, 2025 (PR Newswire)
07:21AM	Cardiol Therapeutics Stock: Is Cannabis Potential Priced In? (Zacks)
Apr-21-25 04:05PM	Jazz Pharmaceuticals Completes Acquisition of Chimerix (PR Newswire)
09:22AM	Sanofi & Regeneron's Dupixent Receives FDA Nod for Urticaria (Zacks)
07:36AM	JAZZ vs. HRMY: Which Neuroscience Drugmaker Is the Stronger Play? (Zacks)
Apr-17-25 11:40AM	JAZZ vs. ARGX: Which Stock Is the Better Value Option? (Zacks)
09:40AM	Why Jazz Pharmaceuticals (JAZZ) is a Top Value Stock for the Long-Term (Zacks)
07:49AM	Is Jazz Pharmaceuticals a Top Cannabis Investment for 2025? (Zacks)
05:06AM	Pharmaceuticals Stocks Q4 In Review: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs Peers (StockStory)
Apr-16-25 11:47AM	Sanofi Advances Mid-to-Late-Stage Pipeline in Respiratory Indications (Zacks)
Apr-15-25 10:42AM	Fate Therapeutics' Lupus Candidate FT819 Gets FDA RMAT Tag (Zacks)
09:18AM	Ironwood Shares Tank on Regulatory Update for Apraglutide (Zacks)
Apr-14-25 09:51AM	Roche Gets Nod for Expanded Use of Columvi in Lymphoma in Europe (Zacks)
Apr-11-25 11:49AM	Arcturus Gets FDA's Fast Track Tag for Influenza Vaccine Candidate (Zacks)
Apr-10-25 03:30PM	Harbor Mid Cap Value Fund Q4 2024 Commentary (Seeking Alpha) -7.33%
11:50AM	TG Therapeutics Shares Rise Almost 30% in 3 Months: Here's Why (Zacks)
11:05AM	TPST to Evaluate Strategic Options for Pipeline Studies, Stock Up (Zacks)
08:13AM	Jazz (JAZZ) Moves 7.1% Higher: Will This Strength Last? (Zacks)
06:20AM	Should John Hancock Multifactor Small Cap ETF (JHSC) Be on Your Investing Radar? (Zacks)
Apr-09-25 03:59PM	Trump's Tariffs Circle Pharma Industry: Who It Affects And How It May Play Out (Seeking Alpha) +7.10%
08:45AM	JAZZ Pharmaceuticals Stock Trades Near 52-Week Low: Time to Buy or Sell? (Zacks)
Apr-08-25 06:56PM	Analyst Report: Jazz Pharmaceuticals plc (Morningstar Research)
Apr-07-25 10:53AM	AZN Gets EU Nod for Expanded Use of Two Separate Cancer Drugs (Zacks)
10:02AM	5 High ROE Stocks to Buy as Markets Face Tariff Bloodbath (Zacks)
06:20AM	Is John Hancock Multifactor Small Cap ETF (JHSC) a Strong ETF Right Now? (Zacks)
Apr-04-25 01:10PM	AMGN's Uplizna Gets FDA Nod for 2nd Rare Autoimmune Disease Indication (Zacks) -8.92%
Apr-03-25 11:27AM	SNY's Rilzabrutinib Gets FDA's Orphan Drug Tag for Two Rare Diseases (Zacks)
Apr-02-25 11:29AM	AXSM Stock Down on Top-Line Data From Depression Study on Solriamfetol (Zacks)
09:33AM	Alkermes Begins Idiopathic Hypersomnia Study on ALKS 2680 (Zacks)
Apr-01-25 10:55AM	VRTX Provides Mixed Updates for Type 1 Diabetes Pipeline Candidates (Zacks)
09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Mar-31-25 11:40AM	JAZZ or ARGX: Which Is the Better Value Stock Right Now? (Zacks)
Mar-29-25 04:15PM	Is Jazz Pharmaceuticals (JAZZ) the Best Mid Cap Biotech Stock to Buy? (Insider Monkey)
Mar-28-25 09:26AM	BEAM's IND for BEAM-302 in Genetic Disorder Study Gets FDA Clearance (Zacks)
Mar-27-25 11:36AM	NTLA Genome-Editing Therapy Gets FDA's RMAT Tag for New Indication (Zacks)
11:30AM	Jazz (JAZZ) Down 9.2% Since Last Earnings Report: Can It Rebound? (Zacks)
07:30AM	Franklin Biotechnology Discovery Fund Q4 2024 Commentary (SeekingAlpha)
Mar-26-25 04:15PM	Jazz Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference (PR Newswire)
11:51AM	AXSM Stock Down Despite ADHD Study Meeting Primary Endpoint (Zacks)
Mar-25-25 05:39PM	Is Jazz Pharmaceuticals plc (JAZZ) a Promising Biotech Stock According to Wall Street Analysts (InsiderMonkey)
Mar-24-25 09:50AM	Why Jazz Pharmaceuticals (JAZZ) is a Top Momentum Stock for the Long-Term (Zacks)
04:26AM	Zacks.com featured highlights include MPLX LP, Leidos, Jazz Pharmaceuticals, Fortinet and Pilgrim's Pride (Zacks)
Mar-22-25 04:09PM	TPB, ACB and JAZZ: Three Pot Stocks Flowering With Potential Upside (TipRanks)
Mar-21-25 12:04PM	5 High ROE Stocks to Buy as Markets Dip Despite Rate Cut Hopes (Zacks)
Mar-20-25 01:03PM	3 Promising Biotechs Trading Substantially Under Consensus Analyst Firm Price Targets (SeekingAlpha)
09:38AM	4 Top PEG Stocks Based on GARP Approach to Smart Investing (Zacks)
Mar-19-25 12:14PM	HRMY Down 10.8% in Six Months: How Should You Play the Stock? (Zacks)
09:55AM	Does Jazz (JAZZ) Have the Potential to Rally 38.94% as Wall Street Analysts Expect? (Zacks)
09:02AM	3 Value Stocks Skating on Thin Ice (StockStory)
07:30AM	Jazz Pharmaceuticals to Showcase Research Demonstrating Treatment Benefits of Xywav (calcium, magnesium, potassium, and sodium oxybates) Oral Solution and Epidiolex (cannabidiol) at American Academy of Neurology Annual Meeting (PR Newswire)
Mar-17-25 11:21AM	Cash In On The Luck Of The Irish With 5 St. Patrick's Day Stocks Near Buy Points (Investor's Business Daily)

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
COZADD BRUCE C	Chairman & CEO	Jul 01 '25	Sale	107.63	1,000	107,630	436,973	Jul 03 02:56 PM
COZADD BRUCE C	Officer	Jul 01 '25	Proposed Sale	107.63	1,000	107,630		Jul 01 04:15 PM
COZADD BRUCE C	Chairman & CEO	Jun 03 '25	Sale	110.00	500	55,000	437,973	Jun 04 04:50 PM
COZADD BRUCE C	Chairman & CEO	Jun 02 '25	Sale	107.90	500	53,950	438,473	Jun 04 04:50 PM
COZADD BRUCE C	Officer	Jun 02 '25	Proposed Sale	108.95	1,000	108,950		Jun 02 05:03 PM
Mulligan Seamus	Director	May 09 '25	Buy	98.26	100,000	9,826,120	100,000	May 13 06:51 PM
Mulligan Seamus	Director	May 12 '25	Buy	103.00	1,621	166,962	101,621	May 13 06:51 PM
COZADD BRUCE C	Chairman & CEO	May 01 '25	Sale	116.35	1,000	116,350	439,307	May 05 07:00 PM
COZADD BRUCE C	Chairman & CEO	May 02 '25	Sale	120.00	500	60,000	438,807	May 05 07:00 PM
COZADD BRUCE C	Officer	May 01 '25	Proposed Sale	117.57	1,500	176,350		May 01 04:09 PM
COZADD BRUCE C	Chairman & CEO	Apr 01 '25	Sale	123.75	1,500	185,625	440,307	Apr 03 05:32 PM
COZADD BRUCE C	Officer	Apr 01 '25	Proposed Sale	125.31	2,000	250,625		Apr 01 04:32 PM
Iannone Robert	EVP, Global Head of R&D & CMO	Mar 10 '25	Sale	138.41	2,403	332,605	79,621	Mar 12 02:24 PM
Carr Patricia	SVP, Chief Accounting Officer	Mar 10 '25	Sale	137.81	1,140	157,103	7,012	Mar 11 06:17 PM
Iannone Robert	Officer	Mar 10 '25	Proposed Sale	145.00	1,767	256,215		Mar 10 06:01 PM
Carr Patricia	Officer	Mar 10 '25	Proposed Sale	137.81	1,140	157,103		Mar 10 05:36 PM
Iannone Robert	EVP, Global Head of R&D & CMO	Mar 07 '25	Sale	138.60	7,080	981,298	82,024	Mar 07 06:49 PM
ROBERT IANNONE	Officer	Mar 07 '25	Proposed Sale	138.73	5,466	758,305		Mar 07 05:14 PM
Iannone Robert	Officer	Mar 07 '25	Proposed Sale	142.26	4,017	571,476		Mar 07 05:04 PM
Henderson Mary Elizabeth	Officer	Mar 07 '25	Proposed Sale	139.00	1,295	180,005		Mar 07 03:15 PM
Carr Patricia	SVP, Chief Accounting Officer	Feb 27 '25	Option Exercise	113.77	4,813	547,562	12,737	Mar 03 07:21 PM
Carr Patricia	SVP, Chief Accounting Officer	Feb 27 '25	Sale	144.42	4,813	695,075	8,237	Mar 03 07:21 PM
Carr Patricia	SVP, Chief Accounting Officer	Feb 28 '25	Sale	143.29	773	110,767	9,485	Mar 03 07:21 PM
Patil Neena M	EVP & Chief Legal Officer	Feb 27 '25	Sale	144.87	3,800	550,506	33,318	Mar 03 07:18 PM
COZADD BRUCE C	Chairman & CEO	Mar 03 '25	Sale	144.25	6,500	937,625	464,058	Mar 03 07:13 PM
COZADD BRUCE C	Officer	Mar 03 '25	Proposed Sale	144.25	6,500	937,625		Mar 03 04:44 PM
Carr Patricia	Officer	Feb 28 '25	Proposed Sale	143.30	773	110,767		Feb 28 05:43 PM
Carr Patricia	Officer	Feb 27 '25	Proposed Sale	139.00	1,641	228,099		Feb 27 08:05 PM
Carr Patricia	Officer	Feb 27 '25	Proposed Sale	144.42	4,813	695,075		Feb 27 05:04 PM
Patil Neena M	Officer	Feb 27 '25	Proposed Sale	144.87	3,800	550,518		Feb 27 04:56 PM
COZADD BRUCE C	Chairman & CEO	Feb 03 '25	Sale	122.31	1,500	183,465	439,744	Feb 05 05:41 PM
COZADD BRUCE C	Officer	Feb 03 '25	Proposed Sale	122.31	1,500	183,465		Feb 03 05:04 PM
COZADD BRUCE C	Chairman & CEO	Jan 02 '25	Sale	123.43	1,500	185,145	425,525	Jan 06 04:22 PM
COZADD BRUCE C	Officer	Jan 02 '25	Proposed Sale	123.43	1,500	185,145		Jan 02 05:00 PM
COZADD BRUCE C	Chairman & CEO	Dec 02 '24	Sale	121.17	2,000	242,340	427,025	Dec 04 05:24 PM
Carr Patricia	SVP, Chief Accounting Officer	Dec 02 '24	Sale	122.49	53	6,492	6,596	Dec 04 05:20 PM
COZADD BRUCE C	Officer	Dec 02 '24	Proposed Sale	121.17	2,000	242,340		Dec 02 06:05 PM
Carr Patricia	Officer	Dec 02 '24	Proposed Sale	122.49	53	6,492		Dec 02 04:20 PM
Patil Neena M	EVP & Chief Legal Officer	Nov 08 '24	Sale	123.41	3,700	456,617	33,048	Nov 13 05:44 PM
Patil Neena M	Officer	Nov 08 '24	Proposed Sale	123.41	3,700	456,632		Nov 08 05:55 PM
COZADD BRUCE C	Chairman & CEO	Nov 01 '24	Sale	110.84	1,000	110,840	428,976	Nov 05 05:00 PM
COZADD BRUCE C	Officer	Nov 01 '24	Proposed Sale	110.84	1,000	110,840		Nov 01 03:19 PM
Henderson Mary Elizabeth	SVP, Technical Operations	Sep 06 '24	Sale	108.30	1,410	152,703	14,531	Sep 11 11:38 AM
Henderson Mary Elizabeth	Officer	Sep 06 '24	Proposed Sale	110.00	2,691	296,010		Sep 05 07:50 PM
Winningham Rick E	Director	Aug 06 '24	Proposed Sale	111.00	3,075	341,325		Aug 05 09:57 PM
Smith Mark Douglas	Director	Aug 06 '24	Proposed Sale	111.00	3,075	341,325		Aug 05 09:55 PM
RIEDEL NORBERT G	Director	Aug 06 '24	Proposed Sale	111.00	3,075	341,325		Aug 05 09:49 PM
ORiordan Anne	Director	Aug 06 '24	Proposed Sale	111.00	3,075	341,325		Aug 05 09:42 PM
O'Keefe Kenneth W	Director	Aug 06 '24	Proposed Sale	111.00	3,075	341,325		Aug 05 09:35 PM
McSharry Heather Ann	Director	Aug 06 '24	Proposed Sale	111.00	3,075	341,325		Aug 05 09:29 PM
Cook Jennifer E.	Director	Aug 06 '24	Proposed Sale	111.00	3,075	341,325		Aug 05 09:19 PM
Sohn Catherine A.	Director	Aug 05 '24	Proposed Sale	111.00	3,075	341,325		Aug 02 04:20 PM

PHR

Phreesia Inc

TDOC

Teladoc Health Inc

JAZZ

Jazz Pharmaceuticals plc

Upgrade your FINVIZ experience